Euroimmun US  |  Products  |  Bone metabolism  |  Cartilage metabolism

Cartilage metabolism

Validated biomarker for cartilage degradation

Supports disease monitoring and treatment response in osteo- and rheumatoid arthritis

Simple, sensitive urine-based ELISA

Background

Cartilage is a strong, pliable, specialized connective tissue that is present in many bony areas of the body where flexibility is needed, such as joints and spinal discs. Cartilage serves many functions in the body, including helping the joints resist friction to move smoothly and absorbing shock from sports and trauma. Cartilage also helps support the shape of joints while connecting other tissues like muscles, tendons, and ligaments to each other and to bone. Cells called chondrocytes are the primary producers of cartilage, which exists in a matrix containing high levels of proteoglycans and glycosaminoglycans, giving cartilage its flexibility and elasticity.1,2

There are three main types of cartilage: hyaline, elastic, and fibrocartilage.

Hyaline cartilage is the most abundant type of cartilage which lines the bones to form joints, connects the ribs to the sternum, and is found in the nasal passages. Composed of type II collagen, proteoglycans and water, it provides a layer that resists compressive forces and mitigates friction1,2.

Elastic cartilage is found in parts of the body where increased flexibility is needed—at the entrance of the trachea and esophagus, at the vocal cords, and the external ear. It is similar to hyaline cartilage, but exhibits more elasticity1,2.

Fibrocartilage is present in areas of the body that resist high levels of mechanical stress including the vertebrae, knee, and other joints where tendons and ligaments attach. It is abundant in type I collagen and contains less proteoglycans than hyaline cartilage1,2.1,2

Cartilage metabolism disorders

Disruption of the structural integrity of cartilage is the major histological finding in osteoarthritis and rheumatoid arthritis. Osteoarthritis is a chronic degenerative joint disease with cartilage degradation. It is the most common type of arthritis—it leads to pain, discomfort, and functional limitations due to “wear and tear” and thinning of cartilage. Rheumatoid arthritis is a systemic autoimmune rheumatic disorder in which the immune system attacks healthy joints—leading to painful swelling, inflammation, and stiffness. While osteoarthritis affects the whole joint, the hyaline cartilage is the most affected tissue of the disorder.2 Early diagnosis of osteoarthritis remains a challenge since no biochemical markers are sufficient to diagnose the disease, which can only be characterized by imaging modalities like CT, MRI, and X-Ray.3 Nonetheless, clinical research suggests that markers of collagen degradation including urinary CTX-II, oligomeric matrix protein (COMP), and hyaluronic acid may be linked to disease severity, joint erosion, and can be useful biomarkers in monitoring osteoarthritis and rheumatoid arthritis.4-7

Disc herniation is the result of the fibrocartilage between vertebrae becoming torn or punctured. When the disc is damaged, it may herniate and impinge upon nearby nerves, resulting in inflammation, neurological dysfunction, lower back and leg pain.2

Product description

  • Type II collagen is the major organic constituent of cartilage.
  • CTX-II is useful in the prediction of the progression of osteoarthritis.4
  • To be used in conjunction with other clinical and laboratory data to monitor disease activity, prognosis, and response to treatment in osteoarthritis and rheumatoid arthritis.6

References

  1. Xia, Y. et al. in Biophysics and Biochemistry of Cartilage by NMR and MRI 1-43 (The Royal Society of Chemistry, 2016).
  2. Chang, L.-R., Marston, G. & Martin, A. 2025    (StatPearls Publishing, 2022).
  3. Martel-Pelletier, J. et al. A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts. Aging Clin Exp Res 31, 19-30, doi:10.1007/s40520-018-1077-8 (2019).
  4. Bjerre-Bastos, J. J. et al. Biomarkers of bone and cartilage turnover CTX-I and CTX-II predict total joint replacements in osteoarthritis. Osteoarthritis and Cartilage 27, S31-S32, doi:10.1016/j.joca.2019.02.046 (2019).
  5. Cheng, H., Hao, B., Sun, J. & Yin, M. C-Terminal Cross-Linked Telopeptides of Type II Collagen as Biomarker for Radiological Knee Osteoarthritis: A Meta-Analysis. Cartilage 11, 512-520, doi:10.1177/1947603518798884 (2020).
  6. Christgau S et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29, 209-215, doi:10.1016/s8756-3282(01)00504-x (2001).
  7. Ritter SY et al. Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis. Arthritis Res Ther 16, 456, doi:10.1186/s13075-014-0456-6 (2014).

Cartilage metabolism products

For in vitro diagnostic use.

For a list of all the products
Euroimmun offers please visit our Product Finder

Contact our Bone metabolism product team
for further details and information

2026 Euroimmun US

Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap